@prefix : <http://scientificvariablesontology.org/svo/matter/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix svo: <http://scientificvariablesontology.org/svo#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

:7%2C12-dimethylbenzo%5Ba%5Danthracene a svo:Matter,
        owl:NamedIndividual ;
    rdfs:label "7,12-dimethylbenzo[a]anthracene"^^xsd:string ;
    svo:has_synonym "7,12-Dimethylbenz[a]anthracene"^^xsd:string ;
    svo:has_wikidata_page "https://www.wikidata.org/wiki/Q187487"^^xsd:string ;
    svo:has_wikipedia_page "https://en.wikipedia.org/wiki/7,12-Dimethylbenz(a)anthracene"^^xsd:string ;
    rdfs:comment "7,12-Dimethylbenz[a]anthracene (DMBA) is an immunosuppressor and a powerful organ-specific laboratory carcinogen. DMBA is widely used in many research laboratories studying cancer. DMBA serves as a tumor initiator. Tumor promotion can be induced with treatments of 12-O-tetradecanoylphorbol-13-acetate (TPA) in some models of two-stage carcinogenesis. This allows for a greatly accelerated rate of tumor growth, making many cancer studies possible."^^xsd:string .

